Arway Announces Share Issuance

Rhea-AI Summary

Arway (OTCQX:ARWYF / CSE:ARWY) completed an issuance of 1,483,824 common shares at a deemed price of C$0.10 per share as consideration for past services on November 18, 2025. The issued shares are subject to a four-month hold period under Canadian Securities Exchange policies.

The securities are not registered under the U.S. Securities Act of 1933 and therefore may not be offered or sold in the United States or to U.S. persons unless properly registered or exempt.

Positive

• 1,483,824 shares issued at C$0.10
• Consideration paid in shares for past services (no cash outflow)

Negative

• Potential shareholder dilution from 1,483,824 new shares
• Issued shares subject to a four-month hold period limiting liquidity
• Securities not registered in the U.S., restricting U.S. trading

TORONTO, ON / ACCESS Newswire / November 18, 2025 / Arway Corporation (the "Company") (OTCQX:ARWYF)(CSE:ARWY) is pleased to announce that it has completed its previously announced issuance of an aggregate of 1,483,824 common shares at a deemed price of Cdn$0.10 per share in consideration of past services.

The shares are subject to a four month hold period in accordance with the policies of the Canadian Securities Exchange.

This news release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful, including any of the securities in the United States of America. The securities described herein have not been and will not be registered under the United States Securities Act of 1933, as amended (the "1933 Act") or any state securities laws and may not be offered or sold within the United States or to, or for account or benefit of, U.S. Persons (as defined in Regulation S under the 1933 Act) unless registered under the 1933 Act and applicable state securities laws, or an exemption from such registration requirements is available.

For further information, please contact:
investor.relations@Nextechar.com
866-ARITIZE (274-8493) Ext 7201

Evan Gappelberg
CEO and Director
866-ARITIZE (274-8493)

Disclaimer for Forward-Looking Information
This news release includes certain statements and information that constitute forward-looking information within the meaning of applicable Canadian securities laws. All statements in this news release, other than statements of historical facts are forward-looking statements. Such forward-looking statements and forward-looking information specifically include, but are not limited to, statements that relate to the anticipated share issuances and the terms thereof, receipt of all applicable regulatory consents in connection therewith. There is no assurance that proposed share issuances will be completed upon terms as presently proposed or at all.

Statements contained in this release that are not historical facts are forward-looking statements that involve various risks and uncertainty affecting the business of the Company. Such statements can generally, but not always, be identified by words such as "expects", "plans", "anticipates", "intends", "estimates", "forecasts", "schedules", "prepares", "potential" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur. All statements that describe the Company's plans relating to operations and potential strategic opportunities are forward-looking statements under applicable securities laws. These statements address future events and conditions and are reliant on assumptions made by the Company's management, and so involve inherent risks and uncertainties, as disclosed in the Company's periodic filings with Canadian securities regulators. As a result of these risks and uncertainties, and the assumptions underlying the forward-looking information, actual results could materially differ from those currently projected, and there is no representation by the Company that the actual results realized in the future will be the same in whole or in part as those presented herein. The Company disclaims any intent or obligation to update forward-looking statements or information except as required by law. Readers are referred to the additional information regarding the Company's business contained in the Company's reports filed with the securities regulatory authorities in Canada. Although the Company has attempted to identify important factors that could cause actual actions, events, or results to differ materially from those described in forward-looking statements, there may be other factors that could cause actions, events or results not to be as anticipated, estimated or intended. For more information on the Company and the risks and challenges of its business, investors should review the Company's filings that are available at www.sedar.com.

The Company provides no assurance that forward-looking statements and information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements or information. Accordingly, readers should not place undue reliance on forward-looking statements or information. The Company does not undertake to update any for-ward looking statements, other than as required by law.

SOURCE: Arway Corporation

View the original press release on ACCESS Newswire

FAQ

How many shares did Arway (ARWYF) issue on November 18, 2025?

Arway issued 1,483,824 common shares on November 18, 2025.

At what price were Arway (ARWYF) shares issued on November 18, 2025?

The shares were issued at a deemed price of C$0.10 per share.

Are the Arway (ARWYF) shares issued on November 18, 2025 tradable immediately?

No; the issued shares are subject to a four-month hold period under CSE policies.

Why were Arway (ARWYF) shares issued on November 18, 2025?

The shares were issued as consideration for past services provided to the company.

Can U.S. investors buy the newly issued Arway (ARWYF) shares?

No; the securities are not registered under the U.S. Securities Act and may not be offered or sold in the U.S. or to U.S. persons without registration or an available exemption.